SB
AZN icon

Simmons Bank’s AstraZeneca AZN Stock Holding History

Simmons Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Sell
1,385
-323
-19% -$62.3K 0.02% 309
2025
Q4 		$314K Sell
1,708
-332
-16% -$58.2K 0.02% 288
2025
Q3 		$313K Sell
2,040
-1,798
-47% -$272K 0.02% 288
2025
Q2 		$536K Sell
3,838
-628
-14% -$88K 0.04% 232
2025
Q1 		$657K Sell
4,466
-15,411
-78% -$2.23M 0.05% 207
2024
Q4 		$2.6M Buy
19,877
+340
+2% +$47.6K 0.19% 116
2024
Q3 		$3.04M Buy
19,537
+1,331
+7% +$215K 0.22% 107
2024
Q2 		$2.84M Buy
18,206
+1,331
+8% +$200K 0.21% 105
2024
Q1 		$2.29M Buy
16,875
+5,308
+46% +$703K 0.17% 127
2023
Q4 		$1.56M Buy
11,567
+9,382
+429% +$1.22M 0.13% 148
2023
Q3 		$296K Buy
2,185
+26
+1% +$3.55K 0.03% 282
2023
Q2 		$309K Buy
2,159
+129
+6% +$19K 0.03% 289
2023
Q1 		$282K Hold
2,030
– – 0.02% 299
2022
Q4 		$275K Sell
2,030
-658
-24% -$82.5K 0.02% 304
2022
Q3 		$295K Sell
2,688
-166
-6% -$21.1K 0.03% 290
2022
Q2 		$377K Hold
2,854
– – 0.03% 275
2022
Q1 		$379K Sell
2,854
-101
-3% -$12.1K 0.03% 291
2021
Q4 		$344K Hold
2,955
– – 0.02% 320
2021
Q3 		$355K Buy
+2,955
New +$344K 0.03% 312
2020
Q1 		– Sell
-2,667
Closed -$266K – 336
2019
Q4 		$266K Sell
2,667
-50
-2% -$4.71K 0.02% 315
2019
Q3 		$242K Sell
2,717
-3,125
-53% -$271K 0.02% 328
2019
Q2 		$482K Sell
5,842
-710
-11% -$55.7K 0.05% 268
2019
Q1 		$530K Sell
6,552
-21
-0.3% -$1.66K 0.05% 254
2018
Q4 		$500K Sell
6,573
-575
-8% -$44.9K 0.06% 235
2018
Q3 		$566K Buy
7,148
+2,360
+49% +$179K 0.06% 244
2018
Q2 		$335K Buy
4,788
+203
+4% +$14.6K 0.03% 294
2018
Q1 		$320K Buy
+4,585
New +$318K 0.03% 293

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Simmons Bank's AZN Position: Q1 2026 in Review

Simmons Bank reduced its AstraZeneca (AZN) stake by 19% in Q1 2026, selling an estimated $62.3K and leaving 1,385 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #309.

Simmons Bank first reported a position in AZN in Q1 2018 and has held it in 27 quarters since. The position peaked at $3.04M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Simmons Bank held 1,385 shares of AstraZeneca worth $273K as of Q1 2026.
  • Simmons Bank sold 323 AstraZeneca shares in Q1 2026, an estimated $62.3K.
  • AstraZeneca made up 0.02% of Simmons Bank's portfolio in Q1 2026, its #309 holding.
  • Simmons Bank first reported a position in AstraZeneca in Q1 2018 and has held it in 27 quarters since.
  • Simmons Bank's AstraZeneca position peaked at $3.04M in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Simmons Bank's 13F filing for Q1 2026, filed 23 Apr 2026.